Cervarix Vaccine 1Dose 0.5Ml provides protection against human papillomavirus (HPV), which causes cervical cancer in women.
Cervarix is a vaccine used to prevent cervical cancer. It can be administered to females from the age of 9 years to protect against HPV-related cancers.
Ages 9–14 years: Two doses of 0.5 ml each. The second dose is given 5–13 months after the first dose.
Ages 15 years and older: Three doses of 0.5 ml each. The second dose is given 1 month after the first dose, and the third dose 6 months after the first dose.
Cervarix is administered via intramuscular injection into the deltoid muscle (upper arm).
Common side effects may include:
Headache
Dizziness
Gastrointestinal disturbances such as nausea, vomiting, or diarrhea
Itching
Skin rash
Joint pain
Do not use Cervarix vaccine in cases of hypersensitivity to any of its components.
Fainting may occur after vaccination, particularly in adolescents, as a psychological response to needle injection.
The vaccine protects only against HPV types 16 and 18.
Cervarix is preventive; it does not treat existing HPV infection or cancers caused by HPV.
Avoid use during pregnancy or when planning to become pregnant.
Consult a doctor before receiving Cervarix during breastfeeding.
Store in a refrigerator at 2–8°C.
Do not freeze.
Keep in the original packaging, protected from light.
Use immediately after opening. If not used right away, keep refrigerated. Discard if not used within 6 hours.